There were 143 press releases posted in the last 24 hours and 437,674 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Zealand Pharma discloses amylin as the biological target under their 2014 agreement with Boehringer Ingelheim

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image